• Biologie

  • Aberrations chromosomiques

  • Voies aérodigestives supérieures

Common and complex Notch1 mutations in Chinese oral squamous cell carcinoma

Menée sur 51 échantillons tumoraux prélevés sur des patients chinois atteints d'un carcinome épidermoïde de la cavité buccale, cette étude analyse la fréquence des mutations du gène Notch1 et leur association avec le pronostic de la maladie

Purpose: To determine Notch1 mutation status in oral squamous cell carcinoma (OSCC) from Chinese population and its potential clinical implications. Experimental Design: Surgically resected OSCC tissues from 51 Chinese patients and 13 head and neck cancer (HNSCC) cell lines were sequenced for mutations in the entire coding regions of Notch1 and TP53 using a next-generation sequencing platform. Sequences of the genes were also determined in corresponding normal tissues from 46 of the 51 patients. Mutations and their association with clinical parameters were analyzed. Results: Six mutations in Notch1 and 11 mutations in TP53 coding regions were detected in 4 (31%) and 10 (77%) of the 13 HNSCC cell lines, respectively. Forty-two somatic Notch1 mutations, including 7 nonsense mutations and 11 mutations within the domain commonly harboring potential activating mutations in ALL, were detected in 22(43%) of the 51 Chinese OSCC tumors. In comparison, 25 somatic TP53 mutations were observed in 21(41%) of the 51 tumors. Patients whose tumors carried Notch1 mutation had a significantly shorter overall and disease-free survivals (P=.004 and P=.001, respectively, by log-rank test) compared to those whose tumors carried no Notch1mutation.Multivariate analysis showed that both Notch1 mutation and lymph node metastasis are independent prognostic factors in the patient population (P=.001). All 15 patients with both Notch1 mutation and nodal metastasis recurred or metastasized within 2 years after surgery. Conclusions: Notch1 mutation is common in Chinese OSCC and associates with clinical outcomes. The complexity of the mutation spectrum warrants further investigation of Notch1 in Chinese patients with OSCC.

Clinical Cancer Research

Voir le bulletin